Author name: admin

Moving on to the subject of this post, I do believe Ivermectin is one of the most relevant repurposed drugs in terms of its potential to add value in oncology. However, this is not the only reason that motivates me now to write about it. Instead, it is because of multiple questions of people regarding the most common and relevant Ivermectin doses used in oncology. As a result, the post below will give a specific attention to that aspect. Next to that, the other very important reason to me is that positive case reports started to emerge, after its use by oncology cancer patients.

As a practicing physician with decades of experience in teaching, it makes sense for me to speak out now about the colossal effectiveness of safe, cheap and readily accessible repurposed drugs now showing life-saving qualities for cancer patients.

She battled long-COVID, which she didn’t even know existed, for 11 months, until someone she met by chance gave her some ivermectin. In less than an hour she already felt like my normal self again. Listen to her story from Japan now.

“Traditional medicine does not like challenges to the status quo,” Dr. Paul Marik

Betsy Ashton hosts Dr. Marik and Dr. Mobeen Syed (Dr. Been) to discuss Dr. Marik’s new monograph, “Cancer Care: The Role of Repurposed Drugs

The gentleman, Rick, had widespread metastatic disease affecting the liver and lymph nodes and was told his cancer was “unsurvivable.” At most, he had six months left, according to his Oncologist.

Following adding Ivermectin, his tumor markers dropped from 1489 to 4.7, and his metastases calcified and shrunk. This was felt due to the anti-metastatic effect of Ivermectin as it suppresses the WnT Pathway, which cancer stem cells rely upon.

Ivermectin is often recognized – 2nd to penicillin – for having the greatest impact on human health. And its discovery won the Nobel Prize in 2015.

But its existence threatened a $200 billion vaccine enterprise…

In 2004, the US Congress passed an amendment to the Federal Food, Drug and Cosmetic Act known as Emergency Use Authorization (EUA). This piece of legislature legalized an anti-regulatory pathway to allow experimental medical interventions to be expedited without proper safety evaluation in the event of bioterrorist threats and national health emergencies such as pandemics. At the time, passage of the EUA amendment made sense because it was partially in response to the 2001 anthrax attacks and the US’s entry into an age of international terrorism. However, the amendment raises some serious considerations.

Is the FDA doing science or peddling narratives? Because it looks like the agency has been caught in one of the biggest lies of the century.

The case brought by Drs. Paul Marik, Mary Bowden, and Robert Apter is now at the Court of Appeals. I was interviewed for this awesome Federalist article today where I landed some powerful blows.